NXTS Stock Summary and Trading Ideas (Nexentis Technologies | NASDAQ:NXTS)

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

What symbol and exchange does Nexentis Technologies shares trade?

Nexentis Technologies trades on the NASDAQ stock market under the symbol NXTS.

What is Nexentis Technologies stock price doing today?

As of June 18, 2026, NXTS stock price declined to $5.08 with 69,429 million shares trading.

What is Nexentis Technologies's Beta?

NXTS has a beta of 1.18, meaning it tends to be more sensitive to market movements. NXTS has a correlation of 0.05 to the broad based SPY ETF.

How much is Nexentis Technologies worth?

NXTS has a market cap of $3.71 million. This is considered a Sub-Micro Cap stock.

What are the support and resistance levels for Nexentis Technologies (NXTS)?

NXTS support price is $4.73 and resistance is $5.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NXTS shares will trade within this expected range on the day.